NCT00592930View on ClinicalTrials.gov

Olanzapine in the Treatment of Anorexia Nervosa

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

Anorexia Nervosa

Interventions

DRUG

olanzapine

flexibly dosed oral olanzapine 2.5 to 15 mg/day

DRUG

placebo

Trial Locations (1)

11040

Schneider Children's Hospital, New Hyde Park

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

Northwell Health

OTHER